New Scientist

Why 'Star Wars' Missile Defence Lives On | New Scientist

The difference, says Jeffrey Lewis of Washington DC think tank the New America Foundation, is that instead of a plan mainly meant to "make a political point ...
Jeffrey Lewis | September 23, 2009

Why Dollars Alone Won't Fix US Healthcare | New Scientist

"When people understand, they're less likely to choose expensive, invasive procedures," says Shannon Brownlee of the New America Foundation a think tank ...
Shannon Brownlee | July 29, 2009

Unknown Internet 5: Is There Only One Internet? | New Scientist

"The language changes will accelerate national fragmentation of the internet," warns Tim Wu, professor of technology and law at Columbia University in New York. He predicts this will lead us down a road towards a divided internet: one part controlled ...
Tim Wu | May 1, 2009

Shannon Brownlee in New Scientist | 'Condition Critical: The Medical Crisis Facing America'

In their speeches, both candidates stress increased access. McCain favours tax credits to encourage families to get insurance, while Obama proposes mandatory coverage for children, a new public insurance plan and a requirement for employers to provide health benefits for their workers. Yet each will struggle to widen coverage if they cannot control costs. “We need to do both at the same time,”says Shannon Brownlee, a specialist in health policy with the New America Foundation, a non-partisan think tankin Washington… more
Shannon Brownlee | September 17, 2008

Jeffrey Lewis in New Scientist | 'Iraq Bans Nuclear Tests'

Iraq's move has been welcomed by disarmament experts, though some question its significance. It's good but "relatively meaningless" given the US refusal to ratify, says Jeffrey Lewis from New America Foundation, a think tank based in Washington DC. "This is probably the only non-proliferation benefit the US got out of the Iraq invasion." LINK
Jeffrey Lewis | August 28, 2008

Selling Out

Elias Zerhouni, director of the US National Institutes of Health, last week took one small step along the road to repairing the tainted ethical reputation of government science. New conflict-of-interest rules that he announced will at last bar NIH scientists from moonlighting as consultants for private industry. The move follows a series of investigations by The Los Angeles Times and the US Congress that uncovered extensive financial ties -- many previously undisclosed -- between agency scientists and the drug and… more

Jennifer Washburn | New Scientist | February 12, 2005